Monday, September 12, 2016

Bismuth Subnitrate




In some countries, this medicine may only be approved for veterinary use.

Scheme

USAN

ATC (Anatomical Therapeutic Chemical Classification)

A02BX12

CAS registry number (Chemical Abstracts Service)

0001304-85-4

Chemical Formula

Bi5-H9-N4-O22

Molecular Weight

1462

Therapeutic Categories

Dermatological agent

Treatment of peptic ulcer

Antidiarrhoeal agent

Chemical Name

Bismuth hydroxide nitrate oxide

Foreign Names

  • Bismuthi subnitras ponderosum (Latin)
  • Bismutnitrat, Schweres, basisches (German)
  • Sous-nitrate de Bismuth lourd (French)

Generic Names

  • Bismut(III)-hydroxix-nitrat-oxid (IS)
  • Bismutnitrat, basisches (IS)
  • Bismutnitratoxid (IS)
  • Bismutsubnitrat (IS)
  • Nitrate basique de bismuth (IS)
  • Wismutsubnitrat (IS)
  • Bismuth (sous nitrate de) lourd (PH: Ph. Eur. 6)
  • Bismuth Subnitrate (PH: JP XV, USP 32)
  • Bismuth Subnitrate Heavy (PH: BP 2010, Ph. Eur. 6)
  • Bismuthi subnitras (PH: Ph. Int. 2)
  • Bismuthi subnitras ponderosum (PH: Ph. Eur. 6)
  • Bismutnitrat, Schweres, Basisches (PH: Ph. Eur. 6)

Brand Names

  • Angass
    Medice, Germany


  • Boviseal (veterinary use)
    Bimeda, Ireland


  • Carbo-Pulbit (Bismuth Subnitrate and Charcoal, activated (veterinary use))
    Bayer Tiergesundheit, Austria


  • Orbeseal (veterinary use)
    Pfizer, Austria; Pfizer Animal Health, Belgium; Pfizer Animal Health, Switzerland; Pfizer Animal Health, Finland; Pfizer Animal Health, Italy; Pfizer Animal Health, Netherlands; Pfizer Animal Health, Norway; Pfizer GmbH Tiergesundheit, Germany; Pfizer Santé Animale, France


  • Ripreston (Bismuth Subnitrate and Calcium Carbonate (veterinary use))
    Richter, Austria


  • Teatseal (veterinary use)
    Pfizer Animal Health, Australia; Pfizer Animal Health, New Zealand

International Drug Name Search

Glossary

ISInofficial Synonym
PHPharmacopoeia Name
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment